| The intriguing role of polymorphonuclear neutrophils in antitumor reactions E Di Carlo, G Forni, PL Lollini, MP Colombo, A Modesti, P Musiani BLOOD-NEW YORK- 97 (2), 339-345, 2001 | 532 | 2001 |
| DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice S Rovero, A Amici, E Di Carlo, R Bei, P Nanni, E Quaglino, P Porcedda, ... The Journal of Immunology 165 (9), 5133-5142, 2000 | 407 | 2000 |
| The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. R Ferracini, MF Di Renzo, K Scotlandi, N Baldini, M Olivero, P Lollini, ... Oncogene 10 (4), 739-749, 1995 | 365 | 1995 |
| Vaccines for tumour prevention PL Lollini, F Cavallo, P Nanni, G Forni Nature Reviews Cancer 6 (3), 204-216, 2006 | 361 | 2006 |
| Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice K Boggio, G Nicoletti, E Di Carlo, F Cavallo, L Landuzzi, C Melani, ... The Journal of experimental medicine 188 (3), 589-596, 1998 | 359 | 1998 |
| 2011: the immune hallmarks of cancer F Cavallo, C De Giovanni, P Nanni, G Forni, PL Lollini Cancer Immunology, Immunotherapy 60 (3), 319-326, 2011 | 324 | 2011 |
| Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors K Scotlandi, MC Manara, G Nicoletti, PL Lollini, S Lukas, S Benini, S Croci, ... Cancer research 65 (9), 3868-3876, 2005 | 322 | 2005 |
| Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice P Nanni, G Nicoletti, C De Giovanni, L Landuzzi, E Di Carlo, F Cavallo, ... The Journal of experimental medicine 194 (9), 1195-1206, 2001 | 284 | 2001 |
| Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target K Scotlandi, S Benini, M Sarti, M Serra, PL Lollini, D Maurici, P Picci, ... Cancer research 56 (20), 4570-4574, 1996 | 268 | 1996 |
| Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice K Scotlandi, S Benini, P Nanni, PL Lollini, G Nicoletti, L Landuzzi, M Serra, ... Cancer research 58 (18), 4127-4131, 1998 | 237 | 1998 |
| Cytokines, tumour-cell death and immunogenicity: a question of choice P Musiani, A Modesti, M Giovarelli, F Cavallo, G Forni, PL Lollini, ... Immunology today 18 (1), 32-36, 1997 | 214 | 1997 |
| Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor … A Allione, M Consalvo, P Nanni, PL Lollini, F Cavallo, M Giovarelli, ... Cancer research 54 (23), 6022-6026, 1994 | 210 | 1994 |
| Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice E Quaglino, M Iezzi, C Mastini, A Amici, F Pericle, E Di Carlo, SM Pupa, ... Cancer research 64 (8), 2858-2864, 2004 | 190 | 2004 |
| Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing’s sarcoma cells S Benini, MC Manara, N Baldini, V Cerisano, M Serra, M Mercuri, ... Clinical Cancer Research 7 (6), 1790-1797, 2001 | 177 | 2001 |
| NVP-BEZ235 as a new therapeutic option for sarcomas MC Manara, G Nicoletti, D Zambelli, S Ventura, C Guerzoni, L Landuzzi, ... Clinical Cancer Research 16 (2), 530-540, 2010 | 170 | 2010 |
| Preclinical in vivo study of new insulin-like growth factor-I receptor–specific inhibitor in Ewing's sarcoma MC Manara, L Landuzzi, P Nanni, G Nicoletti, D Zambelli, PL Lollini, ... Clinical cancer research 13 (4), 1322-1330, 2007 | 167 | 2007 |
| Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling C Garofalo, MC Manara, G Nicoletti, MT Marino, PL Lollini, A Astolfi, ... Oncogene 30 (24), 2730-2740, 2011 | 159 | 2011 |
| TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma P Nanni, C De Giovanni, PL Lollini, G Nicoletti, G Prodi Clinical & experimental metastasis 1 (4), 373-380, 1983 | 155 | 1983 |
| Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. R Ferracini, M Olivero, MF Di Renzo, M Martano, C De Giovanni, P Nanni, ... Oncogene 12 (8), 1697-1705, 1996 | 144 | 1996 |
| Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas C Curcio, E Di Carlo, R Clynes, MJ Smyth, K Boggio, E Quaglino, ... The Journal of clinical investigation 111 (8), 1161-1170, 2003 | 138 | 2003 |
Patrizia NanniUniversità di BolognaEmail verificata su unibo.it
